PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAtropa belladonna
Belladonna
Belladonna is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
belladonna alkaloids with phenobartbitalunapproved drug other2013-08-21
belladonna and opiumunapproved drug other2024-01-11
contac goldOTC monograph final2019-03-18
migraine packANDA2017-01-13
phenobarbital with belladonna alkaloidsunapproved drug other2020-08-05
re-pb hyos elixirunapproved drug other2011-01-26
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
A03: Drugs for functional gastrointestinal disorders
A03B: Belladonna and derivatives containing drugs, plain for functional gastrointestinal disorders
A03BA: Belladonna alkaloids, tertiary amines for functional gastrointestinal disorders
A03BA04: Belladonna total alkaloids
A03BB: Belladonna alkaloids, semisynthetic, quaternary ammonium compounds for functional gastrointestinal disorders
A03C: Antispasmodics in combination with psycholeptics
A03CB: Belladonna and derivatives in combination with psycholeptics
A03CB02: Belladonna total alkaloids and psycholeptics
A03D: Antispasmodics in combination with analgesics
A03DB: Belladonna and derivatives in combination with analgesics
A06: Drugs for constipation
A06A: Drugs for constipation
A06AB: Contact laxatives
A06AB30: Contact laxatives in combination with belladonna alkaloids
HCPCS
No data
Clinical
Clinical Trials
328 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.93714161555
Lung diseasesD008171EFO_0003818J98.4161081439
Obstructive lung diseasesD00817361161437
MyopiaD009216EFO_0003927H52.176661337
AsthmaD001249EFO_0000270J451229519
Motion sicknessD009041T75.3157112
VomitingD014839R11.125411
NauseaD009325R11.015511
Healthy volunteers/patients81211
Neuromuscular blockadeD019148132611
Show 74 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
General anesthesiaD0007682226
AnesthesiaD000758235
Abdominal painD015746EFO_0003766R10.91214
Organophosphate poisoningD0620251224
PremedicationD011292222
Breast neoplasmsD001943EFO_0003869C50112
Autonomic nervous system diseasesD001342EFO_0009532G90112
HypospadiasD007021EFO_0004209Q54111
Cerebral infarctionD002544I63111
Replacement arthroplasty kneeD01964511
Show 15 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Alzheimer diseaseD000544EFO_0000249F03213
Prediabetic stateD011236EFO_1001121R73.03112
Glucose intoleranceD018149HP_0000833R73.03112
HypoglycemiaD007003E16.222
Memory disordersD00856922
Status asthmaticusD01322411
Digestive system physiological phenomenaD00406811
Gastrointestinal motilityD00576911
SyndromeD01357711
Near-infrared spectroscopyD01926511
Show 15 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Irritable bowel syndromeD043183EFO_0000555K5822
ConstipationD003248K59.022
RhytidoplastyD01536111
Blood coagulation testsD00178011
Postoperative cognitive complicationsD00007969011
Urinary bladder neoplasmsD001749C6711
Cardiovascular diseasesD002318EFO_0000319I9811
Vascular diseasesD014652EFO_0004264I7711
Sudden death cardiacD016757EFO_000427811
Sudden deathD00364511
Show 30 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameBelladonna
INN
Description
Belladonna or Bella Donna may refer to:
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL2108906
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Belladonna
+
Butabarbital
+
Atropa belladonna
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Belladonna
+
Ergotamine
+
Phenobarbital
+
Atropa belladonna
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
Black-box warning for: Belladonna alkaloids with phenobartbital, Belladonna and opium
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
851 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use